CAMBRIDGE, Mass., Sept. 11 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. will hold a conference call to discuss the outcome of the proxy vote on the proposed reverse merger between Infinity and Discovery Partners International, Inc. (Nasdaq: DPII - News) scheduled for September 12, 2006. The conference call, which will be moderated by Steven Holtzman, CEO of Infinity, will also provide a business overview of the company and a discussion of its lead oncology programs. The call will be held at 8:30 a.m. EDT (5:30 a.m. PDT) on Thursday, September 14, 2006.
